Mizuho raises Texas Instruments stock price target on AI growth

Mizuho lifted its price target on Texas Instruments to $300 from $255 while keeping a Neutral rating, citing the company’s AI data center business, which reached a $563 million quarterly run rate and is expected to grow into 2027. The firm also highlighted improving industrial demand and incremental fabrication demand tied to the SLAB acquisition. The stock trades near its 52-week high at $300.60 and remains expensive at 50.83x P/E, limiting the immediate upside despite stronger long-term fundamentals.

Analysis

The key implication is not the upgraded target itself, but the market’s willingness to pay growth-multiple premiums for a company that still behaves like a cyclical analog asset. If the AI data center contribution is truly on a multiyear ramp, TXN may get re-rated from a late-cycle industrial semiconductor to a “picks-and-shovels AI infrastructure” compounder, which would support multiples closer to the upper end of the peer band. But that re-rating only works if the mix shift persists; otherwise the stock is vulnerable to mean reversion because current valuation already discounts a lot of the recovery.

The second-order winner is SLAB and, more broadly, any supplier tied to the industrial capex and fab-utilization cycle. Incremental demand from an acquired business can improve wafer loading and fixed-cost absorption at TXN’s domestic fabs, which matters more for margin than near-term revenue. That creates a subtle positive loop: better utilization supports gross margin, which supports capex discipline, which then reinforces scarcity value in domestic manufacturing capacity.

The main risk is that consensus is extrapolating a demand trough into a durable upcycle before automotive normalizes. If industrial order momentum stalls or AI-related bookings plateau after the initial deployment wave, the market could quickly de-rate TXN from “quality growth” back to “expensive cyclicality.” On a 6-12 month horizon, the stock looks most vulnerable to any signal that lead-time improvement is inventory restocking rather than true end-demand acceleration.

The contrarian read is that the setup may be better for relative trades than outright longs. TXN’s balance sheet and manufacturing model justify a premium, but the current multiple leaves limited upside unless earnings revisions accelerate materially into 2026-2027. The more attractive expression may be to own beneficiaries of the fab-loading and industrial rebound while fading names where expectations have run too far ahead of actual demand recovery.

Key Decisions for Investors

• Avoid fresh outright longs in TXN at current levels; initiate only on a pullback toward the prior breakout area, with a 6-9 month horizon and a tight stop if AI/industrial commentary weakens.
• Pair trade: long TXN / short a lower-quality analog peer with weaker domestic manufacturing leverage over 3-6 months, but size modestly because TXN already embeds much of the recovery narrative.
• Own SLAB on a 3-12 month view as a secondary beneficiary of the ecosystem re-load; this is a higher-beta way to express the same industrial/AI capex thesis with more upside if utilization improves.
• If holding TXN, consider buying 3-6 month put spreads financed by call overwriting to protect against multiple compression; risk/reward is skewed if revisions pause before 2026 earnings momentum materializes.
• Add TXN only if next-quarter commentary shows sustained AI data-center acceleration and improving industrial bookings; that would justify a re-rating from cyclical multiple to quality-growth multiple.